Market Place

Market Place

Market Place

Menu

Post Enquiry

Post Enquiry

PharmaCompass

Home

Market Place

Market Place

Search
All
API
FDF
Price
Services
Excipients
Enquiries

    Find

    • Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients
    • Finished Drug Formulations Finished Drug Formulations
    • Price Price
    • Excipients Excipients
    • Services Services
    • Market Place Marketplace

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    Consultant-Needed-Insert
    X

    Find Clinical Drug Development Pipelines & Deals | PipelineProspector

    Loading...

    All Data

    Filters Filter refresh
    ×
    FILTER DATA :
    Country filter
      News Type filter
        Company filter
          Product Type filter
            Deal Size filter
              refresh

              Product Type Full Screen

              Companies Full Screen

              ALK

              • Deals

              Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

              DENMARK Denmark

              Post An Enquiry Post An Enquiry

              Virtual Booth Virtual Booth

              AFSSI Connexions 2020

              Participation Not Confirmed

              Update your events

              ALK Enters into Co-Promotion Agreement with Otonomy for OTIPRIO®, the First and Only Single-Dose Treatment for Acute Otitis Externa

              Contact the Supplier

              Lead Product(s): Ciprofloxacin

              Therapeutic Area: Otolaryngology (Ear, Nose, Throat) Product Name: Otiprio

              Highest Development Status: Approved Product Type: Small molecule

              Partner/Sponsor/Collaborator: Otonomy

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Agreement June 17, 2020

              Details:

              Under the terms of the agreement, ALK will have exclusive rights to promote OTIPRIO for AOE to office-based healthcare professionals in the U.S. including ENT physicians, pediatricians and select primary care physicians.

              PharmaCompass__DigitalAd